InterCure Ltd. (INCR)Healthcare | Drug Manufacturers - Specialty & Generic | Herzliya, Israel | NasdaqGM
5.03 USD
+0.08
(1.616%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 11:23 a.m. EDT
The investment case for InterCure is severely compromised by its inability to generate profits despite reporting significant top-line growth. While revenue jumped 43.8% recently, the company remains deeply unprofitable with negative earnings per share and negative free cash flow. This fundamental deterioration is reflected in the stock's multi-year trajectory, which has seen four out of six years of decline, including a catastrophic 69.85% drop in 2023. Although the stock recently rallied off its lows, the underlying business metrics—negative return on equity and assets—suggest the rally may be a speculative bid for a turnaround that has yet to materialize. With no dividend to provide income and a balance sheet showing negative cash generation, the security offers no margin of safety for a long-term holder. The recent 5-for-1 reverse split proposal further signals management's attempt to manage capital structure rather than improve operational performance. Given the persistent losses and the market's evident skepticism regarding the company's ability to turn the corner, the outlook remains deeply bearish. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.081642 |
| AutoETS | 0.081677 |
| MSTL | 0.091526 |
| AutoTheta | 0.096770 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 11.74 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.556 |
| Excess Kurtosis | -0.78 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 46.174 |
| Market Cap | 75,468,952 |
| Forward P/E | -3.40 |
| Beta | 0.64 |
| Profit Margins | -13.22% |
| Website | https://www.intercure.co |
As of Oct. 10, 2026, 11:23 a.m. EDT: Options activity is extremely thin with negligible open interest across all expirations. The lack of meaningful positioning at strikes above or below the current price suggests a lack of speculative conviction in either direction. Implied volatility is elevated relative to the tiny volume, indicating uncertainty rather than a specific directional bet.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.37341774 |
| Address1 | 85 Medinat ha-Yehudim Street |
| All Time High | 49.95 |
| All Time Low | 1.5 |
| Ask | 1.03 |
| Ask Size | 11 |
| Average Daily Volume10 Day | 3,310 |
| Average Daily Volume3 Month | 22,056 |
| Average Volume | 22,056 |
| Average Volume10Days | 3,310 |
| Beta | 0.636 |
| Bid | 1.01 |
| Bid Size | 1 |
| Book Value | 7.591 |
| City | Herzliya |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.03 |
| Current Ratio | 1.478 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 5.16 |
| Day Low | 4.88 |
| Debt To Equity | 46.174 |
| Display Name | InterCure |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,756,731,600 |
| Earnings Timestamp Start | 1,756,386,000 |
| Ebitda | -55,343,000 |
| Ebitda Margins | -0.20482 |
| Eps Forward | -1.48 |
| Eps Trailing Twelve Months | -0.95 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 9 768 0244 |
| Fifty Day Average | 5.16264 |
| Fifty Day Average Change | -0.13263988 |
| Fifty Day Average Change Percent | -0.025692258 |
| Fifty Two Week Change Percent | -37.341774 |
| Fifty Two Week High | 8.1 |
| Fifty Two Week High Change | -3.0700002 |
| Fifty Two Week High Change Percent | -0.37901235 |
| Fifty Two Week Low | 3.4 |
| Fifty Two Week Low Change | 1.6300001 |
| Fifty Two Week Low Change Percent | 0.47941178 |
| Fifty Two Week Range | 3.4 - 8.1 |
| Financial Currency | ILS |
| First Trade Date Milliseconds | 1,548,685,800,000 |
| Float Shares | 6,652,203 |
| Forward Eps | -1.48 |
| Forward P E | -3.3986487 |
| Free Cashflow | -37,432,376 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 285 |
| Fullday Change | -0.12999964 |
| Fullday Change Percent | -2.519373 |
| Fullday Price | 5.03 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.15064 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.38209 |
| Held Percent Institutions | 0.01053 |
| Implied Shares Outstanding | 15,003,767 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-09-01 |
| Ir Website | http://www.resperate.com/investor-relations/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,787,529,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. |
| Long Name | InterCure Ltd. |
| Market | us_market |
| Market Cap | 75,468,952 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_36626000 |
| Most Recent Quarter | 1,767,139,200 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 82,070,605 |
| Open | 4.91 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 972 7 746 05012 |
| Previous Close | 4.95 |
| Price Hint | 2 |
| Price To Book | 0.6626268 |
| Profit Margins | -0.13216 |
| Quick Ratio | 0.91 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0800004 |
| Regular Market Change Percent | 1.6161697 |
| Regular Market Day High | 5.16 |
| Regular Market Day Low | 4.88 |
| Regular Market Day Range | 4.88 - 5.16 |
| Regular Market Open | 4.91 |
| Regular Market Previous Close | 4.95 |
| Regular Market Price | 5.03 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 6,902 |
| Return On Assets | -0.05784 |
| Return On Equity | -0.092650004 |
| Revenue Growth | 0.239 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 15,003,767 |
| Shares Percent Shares Out | 0.00029999999 |
| Shares Short | 4,549 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 8,276 |
| Short Name | Intercure Ltd. |
| Short Percent Of Float | 0.0004 |
| Short Ratio | 0.6 |
| Source Interval | 15 |
| Symbol | INCR |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.95 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.65731 |
| Two Hundred Day Average Change | 0.3726902 |
| Two Hundred Day Average Change Percent | 0.08002263 |
| Type Disp | Equity |
| Volume | 6,902 |
| Website | https://www.intercure.co |
| Zip | 4,676,670 |